Theraclion S.A.
ALTHE.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | €830 | €1,822 | €1,235 | €1,481 |
| % Growth | -54.5% | 47.5% | -16.6% | – |
| Cost of Goods Sold | €8,013 | €2,903 | €4,286 | €6,021 |
| Gross Profit | -€7,183 | -€1,080 | -€3,050 | -€4,540 |
| % Margin | -865.4% | -59.3% | -246.9% | -306.5% |
| R&D Expenses | €0 | €0 | €4,300 | €3,820 |
| G&A Expenses | €0 | €0 | €0 | €0 |
| SG&A Expenses | €968 | €0 | €6 | €224 |
| Sales & Mktg Exp. | €0 | €0 | €0 | €0 |
| Other Operating Expenses | -€1,191 | €2,072 | -€1,083 | -€3,847 |
| Operating Expenses | -€223 | €2,072 | €3,222 | €197 |
| Operating Income | -€6,960 | -€3,154 | -€6,307 | -€4,737 |
| % Margin | -838.6% | -173.1% | -510.5% | -319.9% |
| Other Income/Exp. Net | €219 | -€1,570 | €342 | €94 |
| Pre-Tax Income | -€6,741 | -€4,724 | -€5,966 | -€4,643 |
| Tax Expense | -€984 | -€1,049 | -€1,001 | -€883 |
| Net Income | -€5,757 | -€3,675 | -€4,964 | -€3,760 |
| % Margin | -693.6% | -201.7% | -401.8% | -253.9% |
| EPS | -0.12 | -0.08 | -0.17 | -0.16 |
| % Growth | -49.3% | 52.7% | -6.3% | – |
| EPS Diluted | -0.12 | -0.076 | -0.17 | -0.16 |
| Weighted Avg Shares Out | 46,093 | 45,732 | 29,388 | 22,769 |
| Weighted Avg Shares Out Dil | 46,093 | 48,276 | 29,388 | 22,769 |
| Supplemental Information | – | – | – | – |
| Interest Income | €49 | €31 | €44 | €74 |
| Interest Expense | €0 | €31 | €44 | €136 |
| Depreciation & Amortization | -€220 | €205 | €182 | €131 |
| EBITDA | -€6,960 | -€4,487 | -€5,740 | -€4,404 |
| % Margin | -838.6% | -246.3% | -464.6% | -297.4% |